SCHEMBL8947272

SCHEMBL8947272

CCCCCCCOc1ccc(-c2nnnn2CC(=O)OC)cc1

nearest known ligand 0.57

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
RARB P10826 3/20 0.47
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947125 0.96 L3MBTL1 (0.48) TSHRMAPK1L3MBTL1
SCHEMBL8947283 0.88 ALDH1A1 (0.57) RARBTSHR
SCHEMBL9568775 0.85 NPSR1 (0.50) TSHRMAPK1L3MBTL1
SCHEMBL8947248 0.84 ALDH1A1 (0.61) RARB
SCHEMBL8947184 0.83 LMNA (0.48)
SCHEMBL8947140 0.83 HSD11B1 (0.59) TSHRL3MBTL1
SCHEMBL8947215 0.79 MGLL (0.56)
SCHEMBL8947311 0.78 ALDH1A1 (0.57) TSHRMAPK1L3MBTL1
SCHEMBL8947309 0.75 HSP90AA1 (0.53)
SCHEMBL9568720 0.74 MAPK1 (0.43) MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE35281-E ANTIDIABETIC AGENTS WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1996-06-18 US disclosed
EP-0388967-B1 Aldose reductase inhibitor WAKAMOTO PHARMA CO LTD (JP) 1995-06-28 EP disclosed
US-5055481-A Alleviate diabetic complications WAKAMOTO PHARMACEUTICAL CO., LTD. (JP) 1991-10-08 US disclosed
EP-0388967-A1 Aldose reductase inhibitor Wakamoto Pharmaceutical Co., Ltd. (JP) 1990-09-26 EP disclosed